Atopica 50 mg Capsule is a Health Canada–registered veterinary drug (DIN 02282062) held by Elanco Canada Limited, containing Cyclosporine. Health Canada lists its status as Marketed (status date 02 Feb 2017). Nexara Health has matched 500 registrations of Cyclosporine across 38 other regulated markets, 39 of them in the same strength and dosage form.

Health Canada registration

Cyclosporine registered in other markets

500 registrations of the same molecule in 38 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Cyclosporine worldwide →

Regulator price references for Cyclosporine

Published list or reimbursement prices for Cyclosporine presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Atopica (DIN 02282062) marketed in Canada?

Yes. Health Canada lists DIN 02282062 as Marketed as of 02 Feb 2017.

Who holds the Canadian licence for this product?

Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.

Is Cyclosporine registered outside Canada?

Yes — Nexara Health has matched 500 registrations in 38 other markets, including 39 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02282062, status date 2017-02-02; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, CBZ, CMED, CNOPS liste des medicaments, EDE, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NHS dm+d VMP, PAMI, PBS, SUKL DLP, URPL RPL; price sources: CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02282062, status date 2017-02-02; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, CBZ, CMED, CNOPS liste des medicaments, EDE, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NHS dm+d VMP, PAMI, PBS, SUKL DLP, URPL RPL; price sources: CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS.

Health Canada Drug Product Database (DPD), DIN 02282062, status date 2017-02-02; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, BDA, CBZ, CMED, CNOPS liste des medicaments, EDE, eEKO (Erstattungskodex), EMA centrally authorised, EU national register, FEST (DMP), HPRA, HSA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NHS dm+d VMP, PAMI, PBS, SUKL DLP, URPL RPL; price sources: CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.